Identification of rationale behind success of steroids for treating lupus
Lupus, which is a chronic inflammatory disease, affecting more than 1 million people in the United States alone can be effectively treated with use of steroids.
The biological rationale as to why large doses of corticosteroids (steroids) administered over several weeks can be of great help to lupus patients was revealed by researchers at the UT Southwestern Medical Center.
From News-Medical.Net:
Unlike the anabolic steroids athletes sometimes use illegally to bulk up muscle, corticosteroids are routinely used to treat inflammation in lupus patients. The drugs, however, can cause undesirable side effects including weight gain and acne when taken over long periods of time.
In a study published in a recent issue of Nature, researchers at UT Southwestern and other institutions show in blood cells that giving very high doses of intravenous corticosteroids early and frequently in the course of the disease is more effective at killing the cells that drive lupus than giving the standard limited intravenous steroids followed by high doses of oral corticosteroids over a period of months. The cells used came from lupus patients as well as from animal models of lupus.
Dr. Marilynn Punaro, professor of pediatrics at UT Southwestern and co-author of the study, remarked that administration of high doses of steroids in the preliminary stages and on a regular basis could greatly help in high steroid doses at a later point of time.


A Cochrane Systematic Review has suggested that the risk of an asthma attack relapsing is reduced considerably when a short course of
The FDA-approved drug presently used for providing relief in terms of withdrawal symptoms from substance abuse, Naltrexone, can be used for providing relief to patients suffering from Crohn’s disease.
According to a study by researchers from the UT Southwestern Medical Center, pneumonia patients can expect more benefits coming their way than what could have been attained with the use of antibiotics alone with
Patients with moderate to severe
Corticosteroids may prove to be of little or no use for improving the survival rates in end-stage acute respiratory distress syndrome (ARDS), as per an NIH-sponsored trial.
Corticosteroids are ineffective for improving survival in patients with late-stage acute respiratory distress syndrome (ARDS), according to results from the ARDS Clinical Research Network of the National Heart, Lung, and Blood Institute (NHLBI), part of the
Low levels of vitamin D were found to be linked with minimized lung function and medication use in children with asthma, as per researchers at
Corticosteroid nasal sprays are better than antihistamines when used “as needed” to treat seasonal allergies, according to researchers from the
According to a new study by researchers at
Recent Comments